Principles of Treatment for Type II Respiratory Failure

Respiratory failure is a severe respiratory dysfunction caused by various etiologies, resulting in decreased arterial partial pressure of oxygen (PaO₂), with or without an elevated partial pressure of carbon dioxide (PaCO₂), leading to a cascade of pathophysiological disturbances. Respiratory failure characterized by hypoxemia accompanied by hypercapnia is termed Type II respiratory failure.

The main therapeutic principles for Type II respiratory failure include the following three key aspects: First, identify and address the underlying causes of respiratory failure. The most common clinical cause is chronic obstructive pulmonary disease (COPD); initial management therefore includes antimicrobial therapy, bronchodilators, and antispasmodics to relieve airway obstruction and bronchospasm, thereby optimizing airway ventilation.

Second, improve ventilatory and gas-exchange function. Oxygen therapy is the most commonly employed intervention in clinical practice. For Type II respiratory failure, low-flow oxygen supplementation is recommended, typically maintaining an inspired oxygen concentration no higher than 35%.

Third, support and restore vital organ function. Type II respiratory failure frequently induces pathophysiological changes in multiple organ systems—including the gastrointestinal and nervous systems. Prompt and effective treatment of hypoxia leads to functional improvement across these critical organ systems.